Front > Comment


Norman Bailey  illustration: Gil Gibli The US elections and Israel

Israelis are anxious about the future of the US's pro-Israel stance, but a US president's foreign policy is largely unfettered by Congress.

Shiri Habib-Valdhorn  illustration: Gil Gibli Copaxone holding its own against generic competition

The market share of Teva's drug as of September 2018 was 77%.

Gali Weinreb  illustration: Gil Gibli Migraine market starts to look tough for Teva

The enthusiasm over FDA approval for Teva's migraine treatment has waned.

Amiram Barkat  illustration: Gil Gibli Rising inflation means rate hike sooner rather than later

While leaving the interest rate at 0.1%, the Bank of Israel is preparing the market for a future interest rate hike.

Norman Bailey  illustration: Gil Gibli Opportunities Israel mustn't miss

Not just fear of Iran but also economic ambition is making Arab countries more amenable to cooperation with Israel.

Amiram Barkat  illustration: Gil Gibli S&P's five mistakes

Israel's credit rating upgrade depended on complete failure to perceive which way the wind is blowing in Netanyahu's government.

Amiram Barkat  illustration: Gil Gibli S&P gives vote of confidence in the Israeli economy

Israel's lower debt ratio and budget deficit, and high growth have been impressive achievements over the past decade.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018